PedAM
Pediatric Disease Annotations & Medicines
| Disease | prostate cancer |
| Symptom | C0151825|bone pain |
| Sentences | 11 |
| PubMedID- 26064237 | Together, these data suggest that atrasentan has an effect on cancer-related bone pain and skeletal-events in patients with prostate cancer. |
| PubMedID- 22745584 | Bone metastases have a devastating impact on quality of life and bone pain in patients with prostate cancer and decrease survival. |
| PubMedID- 23861996 | Zoledronic acid is the only bisphosphonate that has statistically shown significant reductions in skeletal morbidity, including bone pain, in patients with metastatic prostate cancer . |
| PubMedID- 26242893 | Methods: four hundred seventy prostate cancer patients with metastatic bone pain who were suitable for local radiotherapy were randomly assigned to radiotherapy (single dose, 8 gy) or intravenous infusion of ibandronate (6mg) in a noninferiority trial. |
| PubMedID- 23853055 | Because guidelines suggest imaging for prostate cancer patients with bone pain (7) and 5.6% to 28.7% of men aged 50 to 80 years have back pain (29), the optimal rate of imaging should not be zero, even among men with low-risk features. |
| PubMedID- 25859413 | Palliative radiotherapy (prt) is primarily employed for palliation of bone pain in patients with castrate-resistant prostate cancer (crpc). |
| PubMedID- 21056263 | Zoledronic acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. |
| PubMedID- 25469306 | Therefore, sr-89 treatment was found to be effective in ameliorating bone pain associated with metastasis from prostate cancer. |
| PubMedID- 20515602 | Samarium-153 treatment of bone pain in patients with metastatic prostate cancer. |
| PubMedID- 26391636 | Radiopharmaceuticals for palliation of bone pain in patients with castration-resistant prostate cancer metastatic to bone: a systematic review. |
| PubMedID- 22991663 | Consequently, for the management of bone pain in patients with prostate cancer, we should consider altering the radiation dose or fraction using high-dose sbrt combining it with treatments such as systemic chemotherapy, zoledronic acid, and painkiller. |
Page: 1